# Study of Two Investigational Pneumococcal Vaccines in Healthy Adults

> **NCT01444339** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 131 (actual)

## Conditions studied

- Pneumococcal Infections
- Streptococcus Pneumoniae Infections
- Pneumococcal Pneumonia

## Interventions

- **BIOLOGICAL:** Pneumococcal Vaccine Formulation 1
- **BIOLOGICAL:** Pneumococcal Vaccine Formulation 2
- **BIOLOGICAL:** Pneumococcal Vaccine Formulation 3
- **BIOLOGICAL:** Pneumococcal Vaccine Formulation 4
- **BIOLOGICAL:** Pneumococcal Vaccine Formulation 5
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01444339
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2011-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01444339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01444339, "Study of Two Investigational Pneumococcal Vaccines in Healthy Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01444339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*